Nimbus
  • About
    • Overview
    • Leadership
    • Board of Directors
    • Investors
    • Contact
  • Science
    • Overview
    • Target Selection
    • Drug Discovery
    • Translational Medicine
    • Clinical Development
  • Pipeline
    • Overview
    • Publications & Presentations
    • For Patients
  • News
    • Press Releases
    • In the News
  • Culture & Careers
    • Overview
    • Community & Giving Back
    • Benefits
    • Open Positions

Archives: In the News Items

Gilead pays Nimbus $200M after fast progress in NASH

Gilead pays $200M milestone to Cambridge biotech Nimbus

Stopping fat synthesis shrinks cancers, study finds

Big Pharma Innovation in Small Places

Gilead to buy Nimbus unit for up to $1.2b

Gilead paying up to $1.2B for Nimbus unit, drug candidate

Posts pagination

Previous page Page 1 … Page 6 Page 7

Recent Posts

  • Nimbus Therapeutics Presents New Mechanistic Data Highlighting Differentiated Biology of Selective SIK2 Inhibitors at IMMUNOLOGY2026™
  • Nimbus Therapeutics to Present Preclinical and Translational Data on Novel SIK2 Inhibitors at 21st Congress of European Crohn’s and Colitis Organisation (ECCO)
  • Nimbus Therapeutics Announces Research Collaboration and License Agreement with Lilly for Novel Oral Obesity Treatment
  • Nimbus Therapeutics Announces Completion of Dose Escalation in Phase 1/2 Clinical Trial of NDI-219216, Novel WRN Inhibitor for MSI-H Tumors
  • Nimbus Therapeutics Announces Initiation of First-in-Human Clinical Trial with NDI-219216, Novel WRN Inhibitor for MSI-H Tumors

Recent Comments

    Archives

    • April 2026
    • February 2026
    • January 2026
    • December 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • November 2024
    • October 2024
    • May 2024
    • March 2024
    • January 2024
    • December 2023
    • October 2023
    • September 2023
    • March 2023
    • February 2023
    • December 2022
    • November 2022
    • October 2022
    • September 2022
    • August 2022
    • May 2022
    • April 2022
    • March 2022
    • February 2022
    • January 2022
    • November 2021
    • September 2021
    • August 2021
    • July 2021
    • May 2021
    • April 2021
    • December 2020
    • November 2020
    • October 2020
    • September 2020
    • June 2020
    • May 2020
    • December 2019
    • September 2019
    • July 2019
    • April 2019
    • March 2019
    • February 2019
    • January 2019
    • October 2018
    • July 2018
    • June 2018
    • March 2018
    • October 2017
    • April 2017
    • January 2017
    • November 2016
    • September 2016
    • May 2016
    • April 2016
    • February 2016
    • December 2015
    • November 2015
    • October 2015
    • September 2015
    • July 2015
    • April 2015
    • March 2015
    • December 2014
    • November 2014
    • September 2014
    • April 2014
    • December 2013
    • November 2013
    • June 2013
    • May 2013
    • February 2013
    • January 2013
    • December 2012
    • November 2012
    • April 2012
    • June 2011
    • March 2011

    Categories

    • Uncategorized

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    Contact

    info@nimbustx.com
    https://www.linkedin.com/company/nimbus-therapeutics?report%2Esuccess=KJ_KkFGTDCfMt-A7wV3Fn9Yvgwr02Kd6AZHGx4bQCDiP6-2rfP2oxyVoEQiPrcAQ7BfLinkedIn
    22 Boston Wharf Road, Floor 9
    Boston, MA 02210 USA
    • Privacy Policy
    © Nimbus Therapeutics.
    https://www.linkedin.com/company/nimbus-therapeutics?report%2Esuccess=KJ_KkFGTDCfMt-A7wV3Fn9Yvgwr02Kd6AZHGx4bQCDiP6-2rfP2oxyVoEQiPrcAQ7BfLinkedIn
    Nimbus Therapeutics logo